ad image

Transduction

1 / 1
Expanding Patient Access to Gene Therapies through AAV Capsid Engineering
AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

Damien Marsic, Ph.D.

Porton Advanced Solutions

PAO-01-23-CL-02-155Feb 06, 2023
Enabling Gene-Edited hMSCs with a Fit-for-Purpose Transduction Agent
Gene Editing

Enabling Gene-Edited hMSCs with a Fit-for-Purpose Transduction Agent

David Alvaro, Ph.D.

Pharma's Almanac

PAO-07-21-CL-06Jul 15, 2021
1 / 1